Raminta Daniulaityte1, Francois R Lamy2, Monica Barratt3, Ramzi W Nahhas4, Silvia S Martins5, Edward W Boyer6, Amit Sheth7, Robert G Carlson2. 1. Center for Interventions, Treatment, and Addictions Research (CITAR), Department of Population and Public Health Sciences, Wright State University Boonshoft School of Medicine, United States; Ohio Center of Excellence in Knowledge-enabled Computing (Kno.e.sis), Department of Computer Science and Engineering, Wright State University, United States. Electronic address: raminta.daniulaityte@wright.edu. 2. Center for Interventions, Treatment, and Addictions Research (CITAR), Department of Population and Public Health Sciences, Wright State University Boonshoft School of Medicine, United States; Ohio Center of Excellence in Knowledge-enabled Computing (Kno.e.sis), Department of Computer Science and Engineering, Wright State University, United States. 3. Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW, Australia; National Drug Research Institute, Faculty of Public Health, Curtin University, Australia; Centre for Population Health; Burnet Institute, Australia. 4. Division of Epidemiology and Biostatistics, Department of Population and Public Health Sciences, Wright State University Boonshoft School of Medicine, United States; Department of Psychiatry, Wright State University Boonshoft School of Medicine, United States. 5. Department of Epidemiology; Columbia University Mailman School of Public Health, United States. 6. Department of Emergency Medicine, Brigham and Women's Hospital, United States. 7. Ohio Center of Excellence in Knowledge-enabled Computing (Kno.e.sis), Department of Computer Science and Engineering, Wright State University, United States.
Abstract
AIMS: The study seeks to characterize marijuana concentrate users, describe reasons and patterns of use, perceived risk, and identify predictors of daily/near daily use. METHODS: An anonymous web-based survey was conducted (April-June 2016) with 673 US-based cannabis users recruited via the Bluelight.org web-forum and included questions about marijuana concentrate use, other drugs, and socio-demographics. Multivariable logistic regression analyses were conducted to identify characteristics associated with greater odds of lifetime and daily use of marijuana concentrates. RESULTS: About 66% of respondents reported marijuana concentrate use. The sample was 76% male, and 87% white. Marijuana concentrate use was viewed as riskier than flower cannabis. Greater odds of marijuana concentrate use was associated with living in states with "recreational" (AOR=4.91; p=0.001) or "medical, less restrictive" marijuana policies (AOR=1.87; p=0.014), being male (AOR=2.21, p=0.002), younger (AOR=0.95, p<0.001), number of other drugs used (AOR=1.23, p<0.001), daily herbal cannabis use (AOR=4.28, p<0.001), and lower perceived risk of cannabis use (AOR=0.96, p=0.043). About 13% of marijuana concentrate users reported daily/near daily use. Greater odds of daily concentrate use was associated with being male (AOR=9.29, p=0.033), using concentrates for therapeutic purposes (AOR=7.61, p=0.001), using vape pens for marijuana concentrate administration (AOR=4.58, p=0.007), and lower perceived risk of marijuana concentrate use (AOR=0.92, p=0.017). CONCLUSIONS: Marijuana concentrate use was more common among male, younger and more experienced users, and those living in states with more liberal marijuana policies. Characteristics of daily users, in particular patterns of therapeutic use and utilization of different vaporization devices, warrant further research with community-recruited samples.
AIMS: The study seeks to characterize marijuana concentrate users, describe reasons and patterns of use, perceived risk, and identify predictors of daily/near daily use. METHODS: An anonymous web-based survey was conducted (April-June 2016) with 673 US-based cannabis users recruited via the Bluelight.org web-forum and included questions about marijuana concentrate use, other drugs, and socio-demographics. Multivariable logistic regression analyses were conducted to identify characteristics associated with greater odds of lifetime and daily use of marijuana concentrates. RESULTS: About 66% of respondents reported marijuana concentrate use. The sample was 76% male, and 87% white. Marijuana concentrate use was viewed as riskier than flower cannabis. Greater odds of marijuana concentrate use was associated with living in states with "recreational" (AOR=4.91; p=0.001) or "medical, less restrictive" marijuana policies (AOR=1.87; p=0.014), being male (AOR=2.21, p=0.002), younger (AOR=0.95, p<0.001), number of other drugs used (AOR=1.23, p<0.001), daily herbal cannabis use (AOR=4.28, p<0.001), and lower perceived risk of cannabis use (AOR=0.96, p=0.043). About 13% of marijuana concentrate users reported daily/near daily use. Greater odds of daily concentrate use was associated with being male (AOR=9.29, p=0.033), using concentrates for therapeutic purposes (AOR=7.61, p=0.001), using vape pens for marijuana concentrate administration (AOR=4.58, p=0.007), and lower perceived risk of marijuana concentrate use (AOR=0.92, p=0.017). CONCLUSIONS:Marijuana concentrate use was more common among male, younger and more experienced users, and those living in states with more liberal marijuana policies. Characteristics of daily users, in particular patterns of therapeutic use and utilization of different vaporization devices, warrant further research with community-recruited samples.
Authors: Elizabeth T Miller; Dan J Neal; Lisa J Roberts; John S Baer; Sally O Cressler; Jane Metrik; G Alan Marlatt Journal: Psychol Addict Behav Date: 2002-03
Authors: Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis Journal: Lancet Date: 2007-07-28 Impact factor: 79.321
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: Vincent Varlet; Nicolas Concha-Lozano; Aurélie Berthet; Grégory Plateel; Bernard Favrat; Mariangela De Cesare; Estelle Lauer; Marc Augsburger; Aurélien Thomas; Christian Giroud Journal: Sci Rep Date: 2016-05-26 Impact factor: 4.379
Authors: L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison Journal: JAMA Psychiatry Date: 2020-08-01 Impact factor: 21.596
Authors: Rachel N Cassidy; Matthew K Meisel; Graham DiGuiseppi; Sara Balestrieri; Nancy P Barnett Journal: Drug Alcohol Depend Date: 2018-05-19 Impact factor: 4.492
Authors: Francois R Lamy; Raminta Daniulaityte; Mussah Zatreh; Ramzi W Nahhas; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson Journal: Drug Alcohol Depend Date: 2017-12-27 Impact factor: 4.492
Authors: Patricia A Cavazos-Rehg; Melissa J Krauss; Shaina J Sowles; Glennon M Floyd; Elizabeth S Cahn; Veronica L Chaitan; Marisel Ponton Journal: Am J Drug Alcohol Abuse Date: 2018-03-07 Impact factor: 3.829
Authors: Raminta Daniulaityte; Mussa Y Zatreh; Francois R Lamy; Ramzi W Nahhas; Silvia S Martins; Amit Sheth; Robert G Carlson Journal: Drug Alcohol Depend Date: 2018-04-11 Impact factor: 4.492